ON 22 January 2021, it was announced with no fanfare that the Ministry of Health (MOH) would be conducting clinical trials for two medicines, Ivermectin and Favipiravi, to determine their efficacy in treating COVID-19.
Health Director-General Tan Sri Dr Noor Hisham Abdullah has acknowledged that Ivermectin “is cheap, easily available and safe for use.” But in Malaysia, it is only licensed for use in animals.
Ivermectin is listed so far as an essential anti-parasitic drug by the World Health Organisation and it is also an approved drug in the US by the Federal Drug Administration (FDA).
Ivermectin, an anti-parasitic & anti-viral drug, was originally developed by the Japanese in 1975. More than 3.7 billion doses have been distributed globally and used by many millions of people during the last 30 years or so, with no reported adverse side effects or deaths from people taking it. Ivermectin has an impeccable safety record second to none.
Many recent studies from around the world have also found Ivermectin to be very effective in both preventing and treating COVID-19.
The global situation has been changing fast in favour of using Ivermectin against COVID-19. The usual argument against Ivermectin (some big pharma firms involved in COVID-19 vaccine development may oppose its use as they understandably feel threatened by it) that “there is insufficient data to support its use” is no longer valid today.
On 26 January 2021, Slovakia became the first European Union nation to approve the use of Ivermectin against COVID-19.
As a result of presentations at the US Senate Hearing (YouTube above) on 7 December 2020 by Dr Pierre Kory, President of FLCCC (Front Line COVID-19 Critical Care) Alliance, along with Dr Andrew Hill, Researcher & Consultant to World Health Organisation (WHO), the US National Institutes of Health (NIH), on 14 January 2021, decided to upgrade Ivermectin from the status of "against" for the treatment of COVID-19 to "neither for or against", thereby making it an option for the doctors concerned to use in preventing and treating COVID-19.
The upgrade by NIH might seem a small step forward for medical legitimacy for Ivermectin to be used against COVID-19, but nevertheless, it was a significant one as it has freed many doctors the option of using Ivermectin against COVID-19 without feeling the undue pressure or burden to do so.
The US Government agencies involved in health have been criticized at the above Senate Hearing for giving due attention to expensive drugs & vaccines with huge commercial interest and funding, and Not being bothered to pay any attention to safe, cheap and effective generic drugs (such as Ivermectin), which would not generate large profits for the big pharma firms.
It makes you wonder what kind of society that they are living in when making profits is so much more important than public health and saving lives of ordinary people.
In view of the worsening case on COVID-19 infections in our country, many unanswered questions and lack of data on the long term safety aspects of the Pfizer experimental mRNA vaccine (which our country has already been ordered) and the current production problems faced by vaccine manufacturers overseas (with the possibility of delays), the government here should have a “PLAN B”. It should quickly approve Ivermectin to provide a safe, cheap and effective “weapon” against COVID-19.
The clinical trials by MOH on the efficacy of Ivermectin can continue but we should not need to wait (and let many more people suffer and die from COVID-19 in the meantime) since Ivermectin has ALREADY been PROVEN to be VERY SAFE over the last 30 years or so.
What have we got to lose by approving Ivermectin today in Malaysia as an option for doctors to prescribe against COVID-19?
MOH has already given Conditional Approval to the controversial Pfizer experimental mRNA vaccine (which was given Emergency Authorisation by their US FDA despite the inconclusive human clinical trials in US) without having to do any clinical trials in Malaysia.
SIGNATORIES
• Dr Abd Kadir Warsi Mohamad (Phd), Persatuan Pengguna Islam Malaysia (PPIM)
• Captain (R) Dr Wong Ang Peng, Persatuan Patriot Kebangsaan (PATRIOT)
• Commissioner of Police (R) Dato’ Shabudin Abdul Wahab, Covid Research Centre, Asian Heritage Museum (AHM) Group
• Tunku Azwil Tunku Abd Razak, Gabungan NGO Islam (GNI)
• Prof Dr Mustafa Ali Mohd, Clinical Pharmacologist & Toxicologist
Media Statement
Sat Feb 06 2021
The global situation has been changing fast in favour of using Ivermectin against COVID-19.
Iran's supreme leader says Hamas leader's death will not halt 'Axis of Resistance'
The "Axis of Resistance", built up with years of Iranian support, includes Hamas, the Lebanese Hezbollah group, the Houthi movement in Yemen, and various Shi'ite groups in Iraq and Syria.
Putin says Russia willing to seek compromises between Iran and Israel
Russia is ready to help seek compromises between arch-foes Israel and Iran, President Vladimir Putin said on Friday, saying these would be difficult but possible.
What proposals will Russia push at the BRICS summit?
The proposal is also to establish a BRICS reinsurance company to allow uninterrupted shipment of goods and key commodities between members.
Indonesia's free meals plan in the spotlight as Prabowo readies for office
Prabowo calls the programme one of the main drivers of economic growth, eventually set to add an estimated 2.5 million jobs.
Astro AWANI's revamped English news website, AWANI International, launches on Oct 21
Astro AWANI's revamped English platform delivers in-depth global news and expert analysis to keep you informed on key developments.
Israeli strikes kill 33 people in Jabalia refugee camp in Gaza, medics say
Residents of Jabalia said Israeli tanks had reached the heart of the camp after pushing through suburbs and residential districts.
Liam Payne's ex-partner calls for media restraint after 'painful' death
Cheryl Tweedy used her statement to urge the media to remember they had a seven-year-old son, Bear, who could read the reports.
Analysts: Indonesia's strong MoF leadership team to boost investor confidence
Sri Mulyani Indrawati as head of Indonesia's Ministry of Finance is expected to instil confidence among investors.
Biden offers both a carrot and a stick to Israel as his term nears an end
Israel has frequently resisted US advice and has caused political difficulties for the Biden administration.
Putin says BRICS will generate most of global economic growth
Russian President Vladimir Putin will host a summit of the group in the city of Kazan on Oct. 22-24.
ISIS Malaysia's perspective of Budget 2025
An excellent rakyat-centric budget under the overarching principle of a caring and humane economy.
Budget 2025: Record increase in STR, SARA aid initiatives
The government will provide a significant boost to the Sumbangan Tunai Rahmah (STR) and Sumbangan Asas Rahmah (SARA) initiatives next year.
Budget 2025: EPF contributions to be made mandatory for foreign workers – PM Anwar
The government plans to make it compulsory for all non-citizen workers to contribute to the Employees Provident Fund (EPF).
What policies to expect from Indonesia's new President Prabowo
Prabowo will be open to foreign investment, his aide has said, such as by offering investors management of airports and sea ports.
Budget 2025: Govt allocates RM470 mil to empower women's participation in PMKS
The Women's Leadership Apprenticeship Program will be intensified as an effort to produce more female corporate personalities.
Israel sends more troops into north Gaza, deepens raid
Residents of Jabalia in northern Gaza said Israeli tanks had reached the heart of the camp, using heavy air and ground fire.
Indonesia ramps up security ahead of Prabowo's inauguration
Prabowo Subianto will be sworn in as Indonesia's president on Sunday with Vice President-elect, Gibran Rakabuming Raka, also taking office.
Immediate allocation of RM150 mil for local authorities, DID to tackle flash floods
Datuk Seri Anwar Ibrahim said this allocation is intended to address the recent flash floods that hit the capital and several major towns.
Budget 2025: Sabah, Sarawak to continue receiving among highest allocations - PM
Sabah and Sarawak continues to be prioritised under Budget 2025, with allocations of RM6.7 billion and RM5.9 billion respectively.
NFOF will be operational in November 2024 with funding of RM1 bil
PM Anwar Ibrahim said NFOF will support venture capital fund managers to invest in startup companies with RM300 million set aside for 2025.